IL140580A0 - Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents - Google Patents

Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents

Info

Publication number
IL140580A0
IL140580A0 IL14058099A IL14058099A IL140580A0 IL 140580 A0 IL140580 A0 IL 140580A0 IL 14058099 A IL14058099 A IL 14058099A IL 14058099 A IL14058099 A IL 14058099A IL 140580 A0 IL140580 A0 IL 140580A0
Authority
IL
Israel
Prior art keywords
isoflavonoid
tumours
treatment
therapeutic composition
cytotoxic agents
Prior art date
Application number
IL14058099A
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of IL140580A0 publication Critical patent/IL140580A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL14058099A 1998-07-15 1999-07-13 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents IL140580A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809059A FR2781154B1 (en) 1998-07-15 1998-07-15 THERAPEUTIC COMPOSITION BASED ON ISOFLAVONOIDS FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS
PCT/FR1999/001715 WO2000003707A1 (en) 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents

Publications (1)

Publication Number Publication Date
IL140580A0 true IL140580A0 (en) 2002-02-10

Family

ID=9528649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14058099A IL140580A0 (en) 1998-07-15 1999-07-13 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents

Country Status (11)

Country Link
EP (1) EP1096929A1 (en)
JP (1) JP2002520357A (en)
KR (1) KR20020006510A (en)
CN (1) CN1139383C (en)
AU (1) AU761417B2 (en)
BR (1) BR9912817A (en)
CA (1) CA2337256A1 (en)
EA (1) EA200100141A1 (en)
FR (1) FR2781154B1 (en)
IL (1) IL140580A0 (en)
WO (1) WO2000003707A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
PL205635B1 (en) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Novel derivatives of genistein and pharmacological agents containing such derivatives
DE60313754T2 (en) * 2002-03-06 2008-01-24 The Medical Research and Education Trust, San Diego BOTANICAL EXTRACT WITH ANTICIPATIVE ACTIVITY INCLUDING ISOLIQUIRITIGENIN
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
DE10337863A1 (en) * 2003-08-18 2005-03-17 Merck Patent Gmbh Use of chromene-4-one derivatives
CA2590048C (en) 2007-05-23 2013-07-16 Institut National De La Recherche Scientifique Cytosine nucleoside analogs and isoflavones and uses thereof
CN106265669A (en) * 2016-08-04 2017-01-04 大连理工大学 Daidzein and the drug regimen of 10 hydroxy camptothecins and application thereof
CN113842387A (en) * 2021-11-19 2021-12-28 大连理工大学盘锦产业技术研究院 Pharmaceutical composition of 10-hydroxycamptothecin and biochanin A and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (en) * 1982-09-09 1994-03-09 理化学研究所 Anti-cancer drug
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829387B2 (en) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 Composition for promoting lipolysis in fat cells
GB9621757D0 (en) * 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions

Also Published As

Publication number Publication date
JP2002520357A (en) 2002-07-09
FR2781154B1 (en) 2001-09-07
BR9912817A (en) 2001-05-08
CN1312712A (en) 2001-09-12
EP1096929A1 (en) 2001-05-09
CN1139383C (en) 2004-02-25
KR20020006510A (en) 2002-01-19
FR2781154A1 (en) 2000-01-21
WO2000003707A1 (en) 2000-01-27
AU4628299A (en) 2000-02-07
CA2337256A1 (en) 2000-01-27
EA200100141A1 (en) 2001-06-25
AU761417B2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
HUS1500001I1 (en) Use of et743 in combination therapy with dexamethasone for treating cancer
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HK1028957A1 (en) Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
HK1074167A1 (en) Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
IL140580A0 (en) Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
HUP0300917A3 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
GB9912159D0 (en) Improvements in and relating to the treatment of water
HUP0401484A3 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
GB0316026D0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
HUP0201605A2 (en) Oral composition containing perlite and use of the perlite as cleaning agent in such compositions
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
AU2001233811A1 (en) Combined use of chemokine ip-10 and interleukin 12 in the preparation of compositions for the treatment of malignant tumors
EP1583543A4 (en) Methods and therapeutic compositions in the treatment of advanced cancer
HUP0105203A3 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use
GB9904252D0 (en) Composition for the treatment of pain
EE200200348A (en) A pharmaceutical composition for use in the treatment of pain
PL355292A1 (en) Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors